S&P 500
(0.13%) 5 187.70 points
Dow Jones
(0.08%) 38 884 points
Nasdaq
(-0.10%) 16 333 points
Oil
(-0.37%) $78.09
Gas
(0.14%) $2.21
Gold
(-0.26%) $2 318.20
Silver
(-0.45%) $27.42
Platinum
(-0.25%) $985.90
USD/EUR
(0.18%) $0.931
USD/NOK
(0.38%) $10.94
USD/GBP
(0.19%) $0.801
USD/RUB
(0.00%) $91.44

Realtime updates for Mizuho Medy Co.,Ltd. [4595.T]

Exchange: JPX Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Upcoming Earnings Alert

Quarter results tomorrow
(bmo 2024-05-09)

Expected move: +/- 0.00%

Last Updated7 May 2024 @ 22:22

-0.30% ¥ 3 355.00

Live Chart Being Loaded With Signals

Commentary (7 May 2024 @ 22:22):

Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan...

Stats
Today's Volume 13 700.00
Average Volume 69 991.00
Market Cap 31.95B
EPS ¥0 ( 2024-02-08 )
Next earnings date ( ¥0 ) 2024-05-09
Last Dividend ¥40.00 ( 2023-06-29 )
Next Dividend ¥0 ( N/A )
P/E 8.47
ATR14 ¥2.38 (0.07%)

Mizuho Medy Co.,Ltd. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Mizuho Medy Co.,Ltd. Financials

Annual 2023
Revenue: ¥10.99B
Gross Profit: ¥8.03B (73.03 %)
EPS: ¥396.27
FY 2023
Revenue: ¥10.99B
Gross Profit: ¥8.03B (73.03 %)
EPS: ¥396.27
FY 2022
Revenue: ¥17.58B
Gross Profit: ¥14.10B (80.20 %)
EPS: ¥822.94

Financial Reports:

No articles found.

Mizuho Medy Co.,Ltd. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
¥0
(N/A)
¥190.00
(N/A)
¥0
(N/A)
¥40.00
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)

Mizuho Medy Co.,Ltd. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.40 - Stable (12.03%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend ¥9.25 2015-12-28
Last Dividend ¥40.00 2023-06-29
Next Dividend ¥0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 12 --
Total Paid Out ¥555.75 --
Avg. Dividend % Per Year 0.00% --
Score 2.82 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 4.40
Div. Directional Score 7.34 --
Next Divdend (Est)
(2024-11-29)
¥0 Estimate 3.26 %
Dividend Stability
0.26 Very Poor
Dividend Score
2.82
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
8035.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
7280.T Ex Dividend Knight 2024-03-28 Annually 0 0.00%
6523.T Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%
5802.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
4544.T Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%
3769.T Ex Dividend Knight 2023-09-28 Annually 0 0.00%
3034.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
1914.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
9436.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
8367.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.3431.5003.134.70[0 - 0.5]
returnOnAssetsTTM0.1991.2003.364.03[0 - 0.3]
returnOnEquityTTM0.2621.5008.2010.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM7.150.80010.008.00[1 - 3]
quickRatioTTM6.380.80010.008.00[0.8 - 2.5]
cashRatioTTM3.821.50010.0010.00[0.2 - 2]
debtRatioTTM0.0511-1.5009.15-10.00[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM41.052.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM41.052.0010.0010.00[0 - 20]
debtEquityRatioTTM0.0618-1.5009.75-10.00[0 - 2.5]
grossProfitMarginTTM0.7351.0001.0891.089[0.2 - 0.8]
operatingProfitMarginTTM0.4691.0002.622.62[0.1 - 0.6]
cashFlowToDebtRatioTTM0.4041.0008.878.87[0.2 - 2]
assetTurnoverTTM0.5800.8009.477.57[0.5 - 2]
Total Score10.28

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM8.481.0009.240[1 - 100]
returnOnEquityTTM0.2622.508.8410.00[0.1 - 1.5]
freeCashFlowPerShareTTM41.052.0010.0010.00[0 - 30]
dividendYielPercentageTTM2.381.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM41.052.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.1351.500-2.430[0.5 - 2]
operatingCashFlowSalesRatioTTM0.03561.000-1.6110[0.1 - 0.5]
Total Score4.40

Mizuho Medy Co.,Ltd.

Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and legionella antigen test kits; mycoplasma pneumoniae antigen test kits; adenovirus antigen test kits; rotavirus and adenovirus antigen test kits; norovirus antigen test kits; group a streptococcal antigen test kits; pregnancy test kits; ovulation test kits; and fecal occult blood test kits. It also offers gene analysis instrument; SARS-CoV-2 detection kits; and mycoplasma pneumoniae nucleic acid kits. In addition, the company engages in import and export activities. It also operates in the United States, Belgium, Finland, Netherlands, Taiwan, Thailand, etc. The company was incorporated in 1977 and is headquartered in Tosu, Japan.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators